Nadia K. Waheed

Company: Ocular Therapeutix

Job title: Chief Medical Officer

Seminars:

Sustained-Release Innovation for Wet AMD & DR with an Intravitreal Implant 3:00 pm

Discuss the limitations of current treatments for retinal diseases like wet AMD and Diabetic Retinopathy, which require frequent intravitreal injections, leading to increased risk of complications and patient discomfort Explore the advantages of AXPAXLI (OTX-TKI), a bioresorbable hydrogel implant designed to provide sustained release of axitinib, offering a broad antiangiogenic effect with the potential to…Read more

day: Day One